PW Medtech Group Limited (HKG:1358)
1.120
-0.030 (-2.61%)
Apr 29, 2026, 4:08 PM HKT
PW Medtech Group Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 150.78 | 153.18 | 106.04 | 739.12 | Upgrade
|
| Depreciation & Amortization | - | 117.73 | 98.24 | 78.58 | 31.41 | Upgrade
|
| Other Amortization | - | 0.02 | 0.02 | 0.01 | 0 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | 0.11 | 7.14 | 0.01 | -731.79 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1.18 | 0.06 | 11.65 | 52.59 | Upgrade
|
| Stock-Based Compensation | - | 18.6 | - | - | - | Upgrade
|
| Provision & Write-off of Bad Debts | - | -2.67 | -4.17 | -2.72 | 1.14 | Upgrade
|
| Other Operating Activities | - | -14.48 | -23.24 | 57.2 | -66.98 | Upgrade
|
| Change in Accounts Receivable | - | 13.95 | -11.49 | -28.46 | 3.71 | Upgrade
|
| Change in Inventory | - | 15.24 | -4.57 | -5.46 | 5.86 | Upgrade
|
| Change in Accounts Payable | - | 7.4 | 5.65 | 40.42 | 2.82 | Upgrade
|
| Change in Unearned Revenue | - | 10.58 | -5.09 | 7.26 | -0.64 | Upgrade
|
| Operating Cash Flow | - | 318.43 | 211.03 | 269.23 | 37.24 | Upgrade
|
| Operating Cash Flow Growth | - | 50.89% | -21.62% | 622.91% | -52.38% | Upgrade
|
| Capital Expenditures | - | -56.5 | -47.31 | -52.46 | -11.32 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.55 | 3.7 | 0.11 | 0.14 | Upgrade
|
| Cash Acquisitions | - | - | - | -1,014 | - | Upgrade
|
| Divestitures | - | - | 35.99 | - | - | Upgrade
|
| Sale (Purchase) of Intangibles | - | -15.58 | -34.61 | -9.4 | - | Upgrade
|
| Sale (Purchase) of Real Estate | - | 0.82 | - | - | - | Upgrade
|
| Investment in Securities | - | -0.25 | 0.73 | 48.83 | 2,770 | Upgrade
|
| Other Investing Activities | - | 50.65 | 43.83 | 35.37 | 57.34 | Upgrade
|
| Investing Cash Flow | - | -20.32 | -26.67 | -1,082 | 2,636 | Upgrade
|
| Long-Term Debt Issued | - | 5.8 | - | - | - | Upgrade
|
| Total Debt Issued | - | 5.8 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -1.5 | -0.67 | -83.64 | -28.42 | Upgrade
|
| Total Debt Repaid | - | -1.5 | -0.67 | -83.64 | -28.42 | Upgrade
|
| Net Debt Issued (Repaid) | - | 4.3 | -0.67 | -83.64 | -28.42 | Upgrade
|
| Repurchase of Common Stock | - | -80.22 | - | -3.06 | - | Upgrade
|
| Common Dividends Paid | - | -134.37 | -71.6 | - | -2,062 | Upgrade
|
| Other Financing Activities | - | -0.37 | 89.8 | 1.54 | -0.6 | Upgrade
|
| Financing Cash Flow | - | -210.66 | 17.53 | -85.16 | -2,091 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 4.89 | 5.84 | -4.6 | 0.63 | Upgrade
|
| Net Cash Flow | - | 92.33 | 207.74 | -902.86 | 582.99 | Upgrade
|
| Free Cash Flow | - | 261.93 | 163.73 | 216.77 | 25.92 | Upgrade
|
| Free Cash Flow Growth | - | 59.98% | -24.47% | 736.25% | -63.14% | Upgrade
|
| Free Cash Flow Margin | - | 34.06% | 24.25% | 40.38% | 9.55% | Upgrade
|
| Free Cash Flow Per Share | - | 0.17 | 0.10 | 0.14 | 0.02 | Upgrade
|
| Cash Interest Paid | - | 0.37 | 0.15 | 0.46 | 0.6 | Upgrade
|
| Cash Income Tax Paid | - | 36.97 | 44.56 | 14.33 | 7.01 | Upgrade
|
| Levered Free Cash Flow | - | 229.94 | 233.51 | -236.55 | 2,229 | Upgrade
|
| Unlevered Free Cash Flow | - | 230.17 | 233.6 | -236.26 | 2,229 | Upgrade
|
| Change in Working Capital | - | 47.17 | -15.5 | 13.76 | 11.74 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.